Prof.dr. A. Boonstra

Biography

André Boonstra received his PhD at the Erasmus MC in Rotterdam. His postdoctoral training as an immunologist on infectious diseases was at the DNAX Research Institute (Palo Alto, USA) and the National Institute for Medical Research Mill Hill (London, UK). Since September 2006 he is heading the viral hepatitis research group at the Department of Gastroenterology and Hepatology of the Erasmus MC. 

​

The main focus of the research group is to better understand the mechanisms that are responsible for liver disease caused by infections with hepatitis viruses (HBV, HCV, HEV), and to determine markers that predict the development of liver cancer.  

The research benefits from extensive expertise on small-animal models, genomics/bio-informatics, and immunology of infectious diseases, as well as biomarker technology.

​

Andre Boonstra contributed to the scientific community by publishing more than 100 research papers and several book chapters, and has been member of advisory boards for Pharma and NIH committees. He is a member of International Coalition for Elimination of HBV (ICE-HBV) and the HBV Forum. 

Andre Boonstra is coordinator of the EU Horizon 2020 grant ESCALON. Together with Jose Debes, he leads the European-South American Collaboration for Assessment of Liver Originated Neoplasia (ESCALON) aimed at improving early detection and diagnosis of cancer to the liver, the bile ducts and the gall bladder.
In addition, he received research grants from various pharmaceutical companies, the Dutch government, and from NWO-ZonMW.